0001209191-18-003457.txt : 20180112
0001209191-18-003457.hdr.sgml : 20180112
20180112173714
ACCESSION NUMBER: 0001209191-18-003457
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180111
FILED AS OF DATE: 20180112
DATE AS OF CHANGE: 20180112
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: TOOMAN CRAIG A
CENTRAL INDEX KEY: 0001201050
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35952
FILM NUMBER: 18526741
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ARATANA THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001509190
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 383826477
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11400 TOMAHAWK CREEK PARKWAY, SUITE 340
CITY: LEAWOOD
STATE: KS
ZIP: 66211
BUSINESS PHONE: 913.353.1000
MAIL ADDRESS:
STREET 1: 11400 TOMAHAWK CREEK PARKWAY, SUITE 340
CITY: LEAWOOD
STATE: KS
ZIP: 66211
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-01-11
0
0001509190
ARATANA THERAPEUTICS, INC.
PETX
0001201050
TOOMAN CRAIG A
C/O ARATANA THERAPEUTICS, INC.
11400 TOMAHAWK CREEK PARKWAY, SUITE 340
LEAWOOD
KS
66211
0
1
0
0
CHIEF FINANCIAL OFFICER
Common Stock
2018-01-11
4
S
0
30000
5.268
D
75024
D
The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 7, 2017. This sale constitutes the final sale under such trading plan.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.250 to $5.355, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
/s/ John C. Ayres, Attorney-in-Fact for Craig A. Tooman
2018-01-12